New triple antiviral drug combination shows early promise for treating COVID-19 in phase 2 randomized trial

Mary P. Humphrey

A two-7 days training course of antiviral therapy with interferon beta-1b, additionally lopinavir-ritonavir and ribavirin, started off within just seven days of displaying COVID-19 signs or symptoms, is risk-free and much more effective at reducing the duration of viral shedding than lopinavir-ritonavir on your own in clients with delicate to moderate ailment.

That’s in accordance to the initially randomized trial of this triple mix therapy involving 127 adults, aged 18 and older, from six public hospitals in Hong Kong.

These early but crucial results, released in The Lancet, do not incorporate severe circumstances of COVID-19, and the authors strain

Read More

Stroke evaluations drop by nearly 40% during COVID-19 pandemic

Mary P. Humphrey

The amount of persons evaluated for signals of stroke at U.S. hospitals has dropped by approximately forty% all through the COVID-19 pandemic, in accordance to a examine led by scientists from Washington College Faculty of Medicine in St. Louis.

The scientists analyzed stroke evaluations at a lot more than 800 hospitals throughout forty nine states and the District of Columbia.

The findings, printed May 8 in the New England Journal of Medicine, are a troubling indication that several persons who expertise strokes may possibly not be trying to get most likely lifetime-saving professional medical treatment.

Guide writer Dr. Akash Kansagra,

Read More